 lack efficaci high-dos leucovorin fluorouracil patient advanc pancreat adenocarcinoma leucovorin cytotox fluorouracil experiment tumor system effect patient colon cancer twenty-two elig patient advanc pancreat adenocarcinoma phase II trial day continu intraven infus rapid intraven inject consecut day hour initi leucovorin infus assess patient complet partial regress minor respons month patient stabl diseas month median surviv week toxic stomat patient diarrhea hospit toxic necessari untreat patient patient median wbc nadir rang /microl median platelet nadir rang /microl combin leucovorin meaning therapeut activ patient adenocarcinoma pancrea moder sever toxic standard treatment patient diseas